Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors
Clinical trial NCT02691793 · COMPLETED
Trial details
- NCT number
- NCT02691793
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-20
- Primary completion
- 2019-08-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.